New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
10:00 EDTVRTX, MEGGF, VMI, KRA, VIAB, PBR, HOG, EVEP, COH, DISCK, CTRPOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Coach (COH) downgraded at BofA/Merrill... (CTRP) downgraded to Outperform from Strong Buy at Raymond James... Discovery Communications (DISCK) downgraded to Neutral from Buy at BTIG... EV Energy (EVEP) downgraded to Hold from Buy at Wunderlich... Harley-Davidson (HOG) downgraded at KeyBanc... Kraton Performance (KRA) downgraded to Neutral from Outperform at Credit Suisse... Meggitt (MEGGF) downgraded to Underweight from Neutral at JPMorgan... Petrobras (PBR) downgraded to Equal Weight from Overweight at Morgan Stanley... Valmont (VMI) downgraded to Neutral from Outperform at Wedbush... Vertex (VRTX) downgraded to Neutral from Buy at H.C. Wainwright... Viacom (VIAB) downgraded to Neutral from Buy at BTIG.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 >>
January 28, 2016
09:47 EDTHOGHarley-Davidson rallies after results
Subscribe for More Information
09:21 EDTHOGHarley-Davidson sees FY16 CapEx $255M-$275M
Subscribe for More Information
09:19 EDTHOGOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Facebook (FB), up 13.9%... Under Armour (UA), up 14.6%... MicroStrategy (MSTR), up 8.9%... Harley-Davidson (HOG), up 8%... Paypal (PYPL), up 6%... Mellanox (MLNX), up 7.9%... Cirrus Logic (CRUS), up 6.2%... Alibaba (BABA), up 4.5%. ALSO HIGHER: Neos Therapeutics (NEOS), up 61.4% after the FDA approved Adzenys XR-ODT for the treatment of ADHD... Exelixis (EXEL), up 4.7% after the U.S. FDA determined the company's New Drug Application for cabozantinib is sufficiently complete... Kinder Morgan (KMI), up 6.7% after being upgraded at Credit Suisse and Stifel. DOWN AFTER EARNINGS: OSI Systems (OSIS), down 21.3%... ServiceNow (NOW), down 22.3%... eBay (EBAY), down 11.5%... InvenSense (INVN), down 10.5%... Juniper Networks (JNPR), down 9.3%... Hologic (HOLX), down 4.4%... Abbott Laboratories (ABT), down 3.6%... Potash (POT), down 2.1%... Qualcomm (QCOM), down 3.6%.
08:50 EDTHOGHarley-Davidson saw roughly 7% CAGR to Outreach customers over last 5 years
Subscribe for More Information
06:59 EDTHOGHarley-Davidson sees Q1 motorcycle shipments of 78K-83K
Subscribe for More Information
06:59 EDTHOGHarley-Davidson sees 2016 motorcycles shipments up 1%-3%
Subscribe for More Information
06:58 EDTHOGHarley-Davidson reports Q4 EPS 22c, consensus 19c
Reports Q4 revenue $1.01B, consensus $1.03B.
05:59 EDTVRTXVertex price target lowered to $143 from $180 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target for Vertex Pharmaceuticals to $143 to reflect reduced cystic fibrosis sales assumptions following the company's Q4 results. The analyst says there is "no surprises" in Vertex's quarter and keeps an Overweight rating on the name.
January 27, 2016
19:30 EDTVRTXOn The Fly: After Hours Movers
UP AFTER EARNINGS: Facebook (FB), up 11.4%... Mellanox (MLNX), up 6.4%... Paypal (PYPL), up 5%... Crown Castle (CCI), up 2.2%... Citrix (CTXS), up 2.4%... Las Vegas Sands (LVS), up 1%... SanDisk (SNDK), up 1%. ALSO HIGHER: Radius Health (RDUS), up 1.2% after announcing a clinical collaboration with Novartis (NVS)... LinkedIn (LNKD) is up 2.4%, Alphabet (GOOG, GOOGL) is up 2.2% and 2.6%, respectively, Netflix (NFLX) is up 1%, (AMZN) is up 2%, and Twitter (TWTR) is up marginally after Facebook reported quarterly results... MGM Resorts (MGM) is up 2.2% and Wynn Resorts (WYNN) is up 2.2%. DOWN AFTER EARNINGS: ServiceNow (NOW), down 16.5%... eBay (EBAY), down 12.8%... United Rentals (URI), down 9.7%... Juniper Networks (JNPR), down 9.6%... Silicon Graphics (SGI), down 9.1%... Discover Financial (DFS), down 7.4%... InvenSense (INVN), down 6.1%... Core Laboratories (CLB), down 4.3%... Vertex Pharmaceuticals (VRTX), down 1.1%. ALSO LOWER: Incyte (INCY), down 12.8% after announcing that it will halt the Phase 2 sub-study of ruxolitinib or placebo in combination with regorafenib after a planned interim analysis of the high CRP subgroup demonstrated that ruxolitinib plus regorafenib did not show a sufficient level of efficacy to warrant continuation.
16:05 EDTVRTXVertex backs FY16 net product revenue guidance for KALYDECO of $670M-$690M
Vertex expects to provide net product revenue guidance for ORKAMBI during 2016 after gaining additional information on the launch of ORKAMBI in the U.S.
16:04 EDTVRTXVertex reports Q4 EPS 17c, consensus 17c
Subscribe for More Information
14:34 EDTHOGNotable companies reporting before tomorrow's open
Subscribe for More Information
14:34 EDTVRTXNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Facebook (FB), consensus 68c... Qualcomm (QCOM), consensus 90c... Texas Instruments (TXN), consensus 69c... McKesson (MCK), consensus $3.13... PayPal (PYPL), consensus 35c... Las Vegas Sands (LVS), consensus 65c... eBay (EBAY), consensus 50c... Crown Castle (CCI), consensus $1.10... Vertex (VRTX), consensus 17c... Discover (DFS), consensus $1.30... SanDisk (SNDK), consensus 89c... ServiceNow (NOW), consensus 8c... Lam Research (LRCX), consensus $1.43... Citrix Systems (CTXS), consensus $1.19... Hologic (HOLX), consensus 42c... Juniper (JNPR), consensus 59c... Cavium (CAVM), consensus 28c... Cirrus Logic (CRUS), consensus 81c.
11:41 EDTHOGHarley-Davidson volatility elevated into Q4 and outlook
Harley-Davidson February call option implied volatility is at 48, March is at 41; compared to its 52-week range of 19 to 49, suggesting large near term price movement into the expected release of Q4 results on January 28.
11:31 EDTHOGEarnings Watch: Analysts remain bearish on Harley-Davidson ahead of Q4 earnings
Harley-Davidson (HOG) is scheduled to report fourth quarter results before the market open on Thursday, January 28, with a conference call scheduled for 9:00 am EDT. Harley-Davidson is a motorcycle manufacturer that produces heavyweight bikes and a complete line of motorcycle parts, accessories, and general merchandise. EXPECTATIONS: Analysts are looking for earnings per share of 19c on revenue of $1.03B, according to First Call. The consensus range for EPS is 11c-24c on revenue of $972.2M-$1.08B. LAST QUARTER: Harley-Davidson reported third quarter EPS of 69c, missing analysts' estimates for 78c, on revenue of $1.32B, which beat the consensus of $1.21B. The company said that dealers worldwide sold 72,178 new Harley-Davidson motorcycles in Q3 compared to 73,217 motorcycles in the year-ago period. In the U.S., dealers sold 48,918 new Harley-Davidson motorcycles in the quarter compared to sales of 50,167 motorcycles in the year-ago period. Harley-Davidson said at the time that it expects to ship 47,000-52,000 motorcycles in Q4 compared to 47,157 motorcycles shipped in the year-ago period. Additionally, the company lowered its motorcycle shipment guidance for fiscal 2015 to 265,000-270,000, which is about flat to down 2% from 2014, a decline from FY shipment guidance of 275,000-281,000 motorcycles. The company said it expects FY15 operating margin of approximately 16%-17% for the motorcycles segment, compared to prior guidance of 18%-19% for full-year operating margin. NEWS: On its last earnings conference call, Harley-Davidson said that due to headwinds in recalls, currency and ramped up competition, its Q3 performance did not meet expectations. CEO Matthew Levatich noted that "We know we can do better, and we will." Recently, The Wall Street Journal said that Levatich plans to ramp up the company's efforts to appeal to younger adults and women in general, planning to raise its marketing spending by 65% in 2016. STREET RESEARCH: On the day after its last earnings report, several analysts were bearish on Harley-Davidson, including BMO Capital and JPMorgan, which downgraded the stock. In November, Barclays analyst Felicia R. Hendrix said the company's management is "too optimistic near-term" on a recovery. On January 21, William Blair analyst Sharon Zackfia believes Harley-Davidson's domestic retail sales trends remained soft in Q4, even as the company began to lap currency-related discounting by competitors that began late last year. Zackfia sees a low-single-digit decline in retail sales growth in the U.S. in Q4, which would be the fifth consecutive quarter of retail sales declines. Zackfia sees Harley's 2016 production growth guidance being cut to 1%-2% from 3%-5%. PRICE ACTION: Over the last three months, Harley-Davidson shares are down about 19%. In late morning trading ahead of its Q4 earnings report, shares are down fractionally.
11:27 EDTVRTXOptions with increasing call volume
Subscribe for More Information
11:17 EDTHOGStocks with call strike movement; AMZN HOG
Subscribe for More Information
10:23 EDTCOHOptions with decreasing implied volatility
Subscribe for More Information
10:04 EDTVRTXHigh option volume stocks: RDN TRXC EEFT CVLT VRTX
09:59 EDTCOHCoach upgraded to Outperform from Peer Perform at Wolfe Research
Subscribe for More Information
1 | 2 | 3 | 4 | 5 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use